Skip to main content
KimeraCHEMS
Display
  • C
  • N
  • O

Calculated reference model · not an experimental or batch-certified structure. All 19 atoms shown.

Model data & sources
  • Heavy atoms only; hydrogens are omitted from the reference display.
  • Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
  • Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
Formula
C14H27N3O2
Method
RDKit ETKDGv3 / MMFF94s calculated reference conformer
Reports
2 on file
Everything shipping from this page today came off this batch. The code is printed on your label, and one certificate covers the whole batch.

Pramiracetam

Nootropics

Published formats

  • Dry-Fill Capsule 60ct/500mg/30g
  • Powder 20g
What is the difference between these?
Dry-Fill Capsule
Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Powder
Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.

Pricing

Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.

Technical Specifications

Batch COA Database ↗
CAS Registry Number68497-62-1
Molecular FormulaC₁₄H₂₇N₃O₂
Molecular Weight269.38
IUPAC DesignationN-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
Physical FormWhite to off-white crystalline powder
Storage RequirementsRefer to product documentation
Other Namesamacetam, Pramiracetamum, Vinpotropil, UNII-4449F8I3LE, 4449F8I3LE, Neupramir, Pramistar, CNS-1879, Ectapram
Capsule Concentration500mg x 60ct
Bulk Powder Quantity20g

Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.

Research Overview

Pramiracetam Research Standard

Pramiracetam is a potent, lipid-soluble derivative of the piracetam scaffold, distinguished by its unique pharmacokinetic profile compared to its water-soluble racetam counterparts. By featuring a lipophilic structure, pramiracetam exhibits increased membrane permeability, facilitating investigations into high-affinity choline uptake (HACU) and intracellular signaling dynamics. In laboratory research, it serves as an advanced cognitive model tool for studying membrane transport mechanisms, synaptic plasticity, and the optimization of neurotransmitter signaling pathways in controlled in vitro environments.

Physical & Handling Properties

Property Specification
Physical Appearance White to off-white crystalline powder

Mechanism of Action & Research Context

Pramiracetam’s research utility is primarily driven by its enhanced lipid solubility, which allows for distinct interaction patterns with cellular components compared to typical hydrophilic racetams.

  • Choline Uptake Modulation: One of the most studied mechanisms is its ability to facilitate high-affinity choline uptake (HACU) in the hippocampus, which is critical for the synthesis of acetylcholine and the maintenance of cholinergic signaling pathways.

  • Membrane Interactions: Its lipophilicity allows it to interact more readily with lipid bilayers. Researchers utilize this to study membrane fluidity and the potential for the molecule to alter the behavior of membrane-bound proteins and ion channels.

  • Signaling Efficacy: In attention-related experimental models, pramiracetam is used to map signal patterns between nerve cells, providing a model for how structural modification of the pyrrolidone nucleus influences cognitive-related signaling networks.

Research Applications

Pramiracetam is a specialized benchmark for high-fidelity studies in cellular biology and neuropharmacology.

Primary fields of in vitro laboratory investigation include:

  • Cholinergic System Modeling: Investigating the kinetics of choline uptake and neurotransmitter synthesis in cultured neuronal tissue.

  • Membrane Biophysics: Studying the transport mechanisms of fat-soluble molecules across cellular barriers in controlled settings.

  • Attention-Pathway Mapping: Researching signal connectivity and synaptic firing patterns associated with cognitive-related signaling.

  • Metabolic Profiling: Testing the influence of the molecule on enzymatic processing and cellular energy utilization pathways.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

References

  • Pentalieri G, et al. (1982) "Pramiracetam: a new nootropic." Current Therapeutic Research. 31: 712–723.

  • Gualtieri F, et al. (2002) "Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs." Current Pharmaceutical Design. 8(2): 125–138.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only - NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Certificates of Analysis

Currently shipping from batch KC-PMR-01.

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.